Inventor · disambiguated record
Hajime Asanuma
Also filed as: ASANUMA HAJIME
11 granted patents·2 pending applications·226 citations·filing 1993–2013
91Inventor score
Top patents by PatentIndex Score
13 records- 0191US5571820AHeterocyclic compoundTAISHO PHARMACEUTICAL CO LTD·Filed 1993·Granted Nov 5, 1996·50 cites·13 claims
- 0286US5753673AQuinolinecarboxylic acid derivativesTAISHO PHARMACEUTICAL CO LTD·Filed 1995·Granted May 19, 1998·78 cites·6 claims
- 0384US7250522B2Method for selective preparation of aryl 5-thio-β-D-aldohexopyranosidesTAISHO PHARMACEUTICAL CO LTD·Filed 2003·Granted Jul 31, 2007·20 cites·14 claims
- 0484US5733917AHeterocyclic compoundTAISHO PHARMACEUTICAL CO LTD·Filed 1996·Granted Mar 31, 1998·37 cites·6 claims
- 0581US7414072B2Aryl 5-thio-β-d-glucopyranoside derivatives and therapeutic agents for diabetes containing the sameTAISHO PHARMACEUTICAL CO LTD·Filed 2003·Granted Aug 19, 2008·14 cites·18 claims
- 0679US7439232B2Heteroaryl 5-thio-β-D-glucopyranoside derivatives and therapeutic agents for diabetes containing the sameTAISHO PHARMACEUTICAL CO LTD·Filed 2004·Granted Oct 21, 2008·13 cites·16 claims
- 0774US7678810B2Thiazole derivativeTAISHO PHARMACEUTICAL CO LTD·Filed 2005·Granted Mar 16, 2010·4 cites·8 claims
- 0870US8461329B2Isoquinoline derivativeTAKAYAMA TETSUO·Filed 2009·Granted Jun 11, 2013·4 cites·14 claims
- 0966US6720424B1Aminobenzoic acid derivativesTAISHO PHARMACEUTICAL CO LTD·Filed 2000·Granted Apr 13, 2004·5 cites·13 claims
- 1056US2010216787A1Thiazole derivativeTAISHO PHARMACEUTICAL CO LTD·Filed 2009·Application pending·0 cites
- 1152US8822503B22-pyridone compoundsKAWAGUCHI TAKANORI·Filed 2011·Granted Sep 2, 2014·1 cites·23 claims
- 1244US9695148B22-pyridone compoundTAISHO PHARMACEUTICAL CO LTD·Filed 2013·Granted Jul 4, 2017·0 cites·8 claims
- 1342US2010298557A1Pyrazolopyrimidine compoundTAISHO PHARMACEUTICAL CO LTD·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hajime Asanuma files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →